NOTE: This disposition is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________ PURDUE PHARMACEUTICAL PRODUCTS L.P., PURDUE PHARMA L.P., TRANSCEPT PHARMACEUTICALS, INC., NKA PARATEK PHARMACEUTICALS, INC., Plaintiffs-Appellants v. ACTAVIS ELIZABETH LLC, NOVEL LABORATORIES, INC., DR. REDDY'S LABORATORIES, INC., DR. REDDY'S LABORATORIES, LTD., Defendants-Appellees PAR PHARMACEUTICAL, INC., TWI PHARMACEUTICALS, INC., Defendants ______________________ 2015-1659 ______________________ Appeal from the United States District Court for the District of New Jersey in Nos. 2:12-cv-05311-JLL-JAD, 2:13-cv-05003-JLL-JAD, Judge Jose L. Linares. ______________________ JUDGMENT ______________________ CHRISTOPHER NEIL SIPES, Covington & Burling LLP, Washington, DC, argued for plaintiffs-appellants. Also represented by ERICA NICOLE ANDERSEN, MICHAEL N.

KENNEDY.

JACOB M. HOLDREITH, Robins Kaplan LLP, Minneap- olis, MN, argued for all defendants-appellees. Defendant- appellee Novel Laboratories, Inc. also represented by MILES FINN, JEFFREY ALAN HOVDEN, OREN D. LANGER, New York, NY.

SAMUEL S. PARK, Winston & Strawn LLP, Chicago, IL, for defendant-appellee Actavis Elizabeth LLC. Also repre- sented by DAN HOANG; CHARLES B. KLEIN, Washington, DC.

JEFFREY B. ARNOLD, Cantor Colburn LLP, Atlanta, GA, for defendants-appellees Dr. Reddy’s Laboratories, Inc., Dr. Reddy’s Laboratories, Ltd. Also represented by STEVEN M. COYLE, NICHOLAS GEIGER, Hartford, CT. ______________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED:

PER CURIAM (LOURIE, DYK, and HUGHES, Circuit Judges).

AFFIRMED. See Fed. Cir. R. 36.

ENTERED BY ORDER OF THE COURT

January 8, 2016 /s/ Daniel E. O’Toole Date Daniel E. O’Toole Clerk of Court